KORIAN (KORI.PA)

FR0010386334 - Common Stock

7.36  -0.29 (-3.79%)

Fundamental Rating

2

Overall KORI gets a fundamental rating of 2 out of 10. We evaluated KORI against 23 industry peers in the Health Care Providers & Services industry. KORI has a medium profitability rating, but doesn't score so well on its financial health evaluation. KORI has a expensive valuation and it also scores bad on growth.



4

1. Profitability

1.1 Basic Checks

KORI had positive earnings in the past year.
In the past year KORI had a positive cash flow from operations.
Each year in the past 5 years KORI has been profitable.
In the past 5 years KORI always reported a positive cash flow from operatings.

1.2 Ratios

KORI has a worse Return On Assets (0.15%) than 76.19% of its industry peers.
With a Return On Equity value of 0.62%, KORI is not doing good in the industry: 76.19% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 2.43%, KORI is doing worse than 66.67% of the companies in the same industry.
KORI had an Average Return On Invested Capital over the past 3 years of 2.49%. This is below the industry average of 5.66%.
Industry RankSector Rank
ROA 0.15%
ROE 0.62%
ROIC 2.43%
ROA(3y)0.36%
ROA(5y)0.75%
ROE(3y)1.49%
ROE(5y)2.76%
ROIC(3y)2.49%
ROIC(5y)3.01%

1.3 Margins

Looking at the Profit Margin, with a value of 0.50%, KORI is doing worse than 76.19% of the companies in the same industry.
KORI's Profit Margin has declined in the last couple of years.
KORI's Operating Margin of 7.54% is fine compared to the rest of the industry. KORI outperforms 76.19% of its industry peers.
KORI's Operating Margin has declined in the last couple of years.
KORI has a better Gross Margin (92.07%) than 95.24% of its industry peers.
In the last couple of years the Gross Margin of KORI has remained more or less at the same level.
Industry RankSector Rank
OM 7.54%
PM (TTM) 0.5%
GM 92.07%
OM growth 3Y-8.77%
OM growth 5Y-3.82%
PM growth 3Y-46.1%
PM growth 5Y-37.51%
GM growth 3Y-0.1%
GM growth 5Y0.03%

0

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so KORI is destroying value.
The number of shares outstanding for KORI has been increased compared to 1 year ago.
KORI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for KORI has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.51, we must say that KORI is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.51, KORI is doing worse than 76.19% of the companies in the same industry.
The Debt to FCF ratio of KORI is 34.46, which is on the high side as it means it would take KORI, 34.46 years of fcf income to pay off all of its debts.
KORI has a worse Debt to FCF ratio (34.46) than 66.67% of its industry peers.
A Debt/Equity ratio of 1.96 is on the high side and indicates that KORI has dependencies on debt financing.
KORI has a worse Debt to Equity ratio (1.96) than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.96
Debt/FCF 34.46
Altman-Z 0.51
ROIC/WACC0.82
WACC2.97%

2.3 Liquidity

A Current Ratio of 0.63 indicates that KORI may have some problems paying its short term obligations.
With a Current ratio value of 0.63, KORI is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
KORI has a Quick Ratio of 0.63. This is a bad value and indicates that KORI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.62, KORI is doing worse than 61.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.63
Quick Ratio 0.62

3

3. Growth

3.1 Past

KORI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -77.10%.
The earnings per share for KORI have been decreasing by -36.91% on average. This is quite bad
KORI shows a small growth in Revenue. In the last year, the Revenue has grown by 7.27%.
KORI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.23% yearly.
EPS 1Y (TTM)-77.1%
EPS 3Y-46.73%
EPS 5Y-36.91%
EPS growth Q2Q-85.96%
Revenue 1Y (TTM)7.27%
Revenue growth 3Y7.1%
Revenue growth 5Y7.23%
Revenue growth Q2Q6.66%

3.2 Future

KORI is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -17.31% yearly.
Based on estimates for the next years, KORI will show a small growth in Revenue. The Revenue will grow by 5.00% on average per year.
EPS Next Y-69.88%
EPS Next 2Y-27.27%
EPS Next 3Y-17.31%
EPS Next 5YN/A
Revenue Next Year8.42%
Revenue Next 2Y7.06%
Revenue Next 3Y6.39%
Revenue Next 5Y5%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 38.74 indicates a quite expensive valuation of KORI.
Based on the Price/Earnings ratio, KORI is valued a bit more expensive than the industry average as 76.19% of the companies are valued more cheaply.
When comparing the Price/Earnings ratio of KORI to the average of the S&P500 Index (26.42), we can say KORI is valued slightly more expensively.
With a Price/Forward Earnings ratio of 24.99, KORI is valued on the expensive side.
66.67% of the companies in the same industry are cheaper than KORI, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.74, KORI is valued at the same level.
Industry RankSector Rank
PE 38.74
Fwd PE 24.99

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of KORI indicates a somewhat cheap valuation: KORI is cheaper than 61.90% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of KORI indicates a rather cheap valuation: KORI is cheaper than 95.24% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.27
EV/EBITDA 8.71

4.3 Compensation for Growth

KORI's earnings are expected to decrease with -17.31% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-27.27%
EPS Next 3Y-17.31%

4

5. Dividend

5.1 Amount

KORI has a Yearly Dividend Yield of 3.27%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.00, KORI pays a better dividend. On top of this KORI pays more dividend than 80.95% of the companies listed in the same industry.
KORI's Dividend Yield is a higher than the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 3.27%

5.2 History

The dividend of KORI is nicely growing with an annual growth rate of 10.51%!
Dividend Growth(5Y)10.51%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

262.13% of the earnings are spent on dividend by KORI. This is not a sustainable payout ratio.
The Dividend Rate of KORI has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP262.13%
EPS Next 2Y-27.27%
EPS Next 3Y-17.31%

KORIAN

EPA:KORI (6/19/2023, 7:00:00 PM)

7.36

-0.29 (-3.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap783.53M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 3.27%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 38.74
Fwd PE 24.99
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.15%
ROE 0.62%
ROCE
ROIC
ROICexc
ROICexgc
OM 7.54%
PM (TTM) 0.5%
GM 92.07%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 1.96
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.63
Quick Ratio 0.62
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-77.1%
EPS 3Y-46.73%
EPS 5Y
EPS growth Q2Q
EPS Next Y-69.88%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)7.27%
Revenue growth 3Y7.1%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y